Thomas Jefferson University

Christopher McGrath

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentPulmonary Diseases
Address800 Walnut Street
Philadelphia PA 19107
Phone215-952-1651
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Johnson JA, Mallari KF, Pepe VM, Treacy T, McDonough G, Khaing P, McGrath C, George BJ, Yoo EJ. Mechanically ventilated COVID-19 patients admitted to the intensive care unit in the United States with or without respiratory failure secondary to COVID-19 pneumonia: a retrospective comparison of characteristics and outcomes. Acute Crit Care. 2023 Aug; 38(3):298-307. PMID: 37652859.
      Citations:    
    2. Kulandaisamy PC, Kulandaisamy S, Kramer D, Mcgrath C. Malignant Pleural Effusions-A Review of Current Guidelines and Practices. J Clin Med. 2021 Nov 26; 10(23). PMID: 34884236.
      Citations:    
    3. McDonough G, Khaing P, Treacy T, McGrath C, Yoo EJ. The Use of High-Flow Nasal Oxygen in the ICU as a First-Line Therapy for Acute Hypoxemic Respiratory Failure Secondary to Coronavirus Disease 2019. Crit Care Explor. 2020 Oct; 2(10):e0257. PMID: 33134947.
      Citations:    
    Co-Authors (3)
    Explore
    _
    Same Department Expand Description
    Explore
    _